Zhongqiang Guo
Overview
Explore the profile of Zhongqiang Guo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
392
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Qi Z, Bai X, Wu L, Zhang P, Guo Z, Yu Y
J Transl Med
. 2024 Jun;
22(1):538.
PMID: 38844946
Apalutamide, a novel endocrine therapy agent, has been shown to significantly improve the prognosis of patients with metastatic hormone-sensitive prostate cancer (mHSPC). However, resistance to apalutamide has also been reported,...
2.
Su B, Zhao W, Shi B, Zhang Z, Yu X, Xie F, et al.
Mol Cancer
. 2023 Apr;
22(1):74.
PMID: 37101172
No abstract available.
3.
Qian K, Wang G, Cao R, Liu T, Qian G, Guan X, et al.
Molecules
. 2022 Oct;
27(19).
PMID: 36235311
During the course of a review of our publications, an inadvertent error in the article [...].
4.
Chen L, Cao R, Wang G, Yuan L, Qian G, Guo Z, et al.
Med Oncol
. 2022 Sep;
39(12):184.
PMID: 36071297
No abstract available.
5.
Xiao Y, Ju L, Qian K, Jin W, Wang G, Zhao Y, et al.
Clin Transl Med
. 2022 Aug;
12(8):e1008.
PMID: 35968916
Background: State-of-art non-invasive diagnosis processes for bladder cancer (BLCA) harbour shortcomings such as low sensitivity and specificity, unable to distinguish between high- (HG) and low-grade (LG) tumours, as well as...
6.
Chen S, Wang Y, Xiong Y, Peng T, Lu M, Zhang L, et al.
Int J Biol Sci
. 2021 Apr;
17(5):1250-1262.
PMID: 33867843
The purpose of our study was to explore the effect and intrinsic mechanism of wild-type IDH1 and its substrate α-KG on renal cell carcinoma (RCC). IDH1 was observed lower expression...
7.
Chen S, Yang Y, Peng T, Yu X, Deng H, Guo Z
Int J Med Sci
. 2020 Jul;
17(10):1366-1374.
PMID: 32624693
To explore the prediction value of PI-RADS v2 in high-grade prostate cancer and establish a prediction model combined with related variables of prostate cancer. A total of 316 patients with...
8.
Chen S, Yang Y, Luo Z, Deng H, Peng T, Guo Z
J Cancer
. 2020 Jun;
11(15):4324-4331.
PMID: 32489451
: To explore the independent risk factors of infection during the intravesical instillation of bladder cancer and establish a prediction model, which may reduce probability of infection for bladder cancer...
9.
Chen S, Zhou Q, Liu T, Zhang W, Zeng X, Guo Z
J Cancer
. 2020 Jan;
11(5):1212-1222.
PMID: 31956367
5-hydroxymethylcytosine (5hmC) is converted from DNA methylation of cytosine (5mC) by the catalysis of TET proteins, and proposed to be involved in tumorigenesis. However, the prognostic value of 5hmC in...
10.
Xu M, Jiang H, Wang H, Liu J, Liu B, Guo Z
Oncol Rep
. 2018 Jun;
40(2):726-736.
PMID: 29917166
The mechanisms of malignant cell metastasis to secondary sites are complex and multifactorial. Studies have demonstrated that small integrin‑binding ligand N‑linked glycoproteins (SIBLINGs), particularly bone sialoprotein (BSP) and osteopontin (OPN),...